Roger Adsett - 04 Jan 2024 Form 4 Insider Report for INSMED Inc (INSM)

Reporting relationship: Chief Operating Officer
Issuer ticker: INSM
Reported as of: 04 Jan 2024
Net transaction value: -$88,864
SEC form: 4
Accepted by SEC: 05 Jan 2024, 17:26:47 UTC
Prior SEC filing: 15 Jun 2023
Next SEC filing: 11 Jan 2024
Source filing: View source filing
Reporting owner signature: /s/ Roger Adsett, by Michael A. Smith as Attorney in Fact

Filing notes and source

Key filing fact

Roger Adsett filed Form 4 for INSMED Inc (INSM) on 05 Jan 2024.

Key facts

This page summarizes Roger Adsett's Form 4 filing for INSMED Inc (INSM).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 05 Jan 2024, 17:26.

Change

Previous filing in this sequence was filed on 15 Jun 2023.
Current net transaction value: -$88,864.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSM transaction

Common Stock

Award

Transaction value
Shares: +12,873
Change %: +8.5%
Price
Shares after: 164,225
Date: 04 Jan 2024
Ownership: Direct
Footnotes: F1, F2

INSM transaction

Common Stock

Sale

Transaction value: $88,864
Shares: -3,042
Change %: -1.9%
Price: $29.21
Shares after: 161,183
Date: 05 Jan 2024
Ownership: Direct
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

INSM transaction Derivative

Stock Option (right to buy)

Award

Transaction value: $0
Shares: +63,560
Change %
Price: $0.000000
Shares after: 63,560
Date: 04 Jan 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 63,560
Exercise price: $29.13
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the date of the grant.

Footnote F2

Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration.

Footnote F3

Shares sold to satisfy withholding tax obligations upon the vesting of Restricted Stock Units and to cover related broker fees.

Footnote F4

Stock options granted under the Company's Amended and Restated 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary date of the date of grant.